KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to -$222.0 million.

  • Amgen's Change in Receivables fell 16491.23% to -$222.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 14258.06%. This contributed to the annual value of -$441.0 million for FY2024, which is 14344.83% down from last year.
  • As of Q3 2025, Amgen's Change in Receivables stood at -$222.0 million, which was down 16491.23% from $515.0 million recorded in Q2 2025.
  • In the past 5 years, Amgen's Change in Receivables ranged from a high of $1.3 billion in Q1 2025 and a low of -$486.0 million during Q1 2024
  • Its 5-year average for Change in Receivables is $176.3 million, with a median of $176.0 million in 2024.
  • Per our database at Business Quant, Amgen's Change in Receivables surged by 45178.57% in 2022 and then crashed by 43750.0% in 2024.
  • Over the past 5 years, Amgen's Change in Receivables (Quarter) stood at $160.0 million in 2021, then increased by 12.5% to $180.0 million in 2022, then soared by 140.56% to $433.0 million in 2023, then tumbled by 209.24% to -$473.0 million in 2024, then surged by 53.07% to -$222.0 million in 2025.
  • Its Change in Receivables was -$222.0 million in Q3 2025, compared to $515.0 million in Q2 2025 and $1.3 billion in Q1 2025.